Evaluation of Safety and Efficacy of the BACE™ Device in the Treatment of Functional Mitral Valve Regurgitation [FMR (BACE)
Evaluation of Safety and Efficacy of the Basal Annuloplasty of the Cardia Externally (BACE™) [Basal Annuloplasty of the Cardia Externally] Device in the Treatment of Functional Mitral Valve Regurgitation [FMR]
Sponsor: Phoenix Cardiac Devices, Inc.
A NA clinical study on Functional Mitral Regurgitation, this trial is ongoing. The trial is conducted by Phoenix Cardiac Devices, Inc. and has accumulated 9 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Active Not Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Enrolling By Invitation → Active Not Recruiting
▶ Show 4 earlier versions
-
Sep 2019 — Oct 2020 [monthly]
Enrolling By Invitation NA
-
Apr 2019 — Sep 2019 [monthly]
Enrolling By Invitation NA
Phase: PHASE1 → NA
-
Jun 2018 — Apr 2019 [monthly]
Enrolling By Invitation PHASE1
-
Jan 2017 — Jun 2018 [monthly]
Enrolling By Invitation PHASE1
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Phoenix Cardiac Devices, Inc.
- Toronto General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.